High-Fidelity and Cost-Effective Engineering of SARS-CoV-2
Viruses · 2025
DOI: 10.3390/v17121604 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Marco Olguin-Nava und 12 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz Institute for RNA-Based Infection Research, Helmholtz Centre for Infection Research, 97080 Würzburg, Germany. Hauptthemen laut MEDLINE: SARS-CoV-2, Reverse Genetics. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helmholtz Association of German Research Centres, Agence Nationale de la Recherche, Helmholtz Association.
Abstract (Originalsprache)
Efficient reverse genetics systems are essential for understanding SARS-CoV-2 pathogenesis, host–virus interactions, and potential therapeutic interventions. Here, we developed a cost-effective PCR-based reverse genetics platform that splits the SARS-CoV-2 genome into only six bacterial plasmids, enabling cloning, manipulation, and the rescue of recombinant SARS-CoV-2 (rSARS-CoV-2) with high fidelity and high viral titers after a single passage. Using this system, we generated and characterized spike protein mutants Y453F and N501Y, as well as a U76G mutation in the 5′-UTR. Y453F showed reduced replication kinetics, lower cell binding, and diminished fitness, while N501Y exhibited comparable replication and fitness, highlighting the distinct effects of these spike protein mutations. The U76G mutation is located within a novel NSP9 binding site in the 5′-UTR and leads to impaired RNA synthesis and reduced viral replication efficiency, suggesting an important role in transcription and replication. Our findings highlight the robustness and adaptability of this reverse genetics system, providing a versatile, cost-effective tool for studying SARS-CoV-2 mutations and their effects on replication and fitness, with potential applications in vaccine and therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Helmholtz Institute for RNA-Based Infection Research, Helmholtz Centre for Infection Research, 97080 Würzburg, Germany.
- Institute of Virology, Hannover Medical School, 30625 Hannover, Germany.
- Institute of Virology and Immunology, University of Würzburg, 97080 Würzburg, Germany.
- Institute of Medical Virology, Goethe-University Frankfurt, 60596 Frankfurt am Main, Germany.
- Architecture et Réactivité de l'ARN, Institute of Molecular and Cellular Biology, CNRS, University of Strasbourg, 67084 Strasbourg, France.
- Hannover Medical School, 30625 Hannover, Germany.
ORCID-Profile: Patrick Bohn, Uddhav B Ambi, Alexander Gabel, Lina M Günter, Nora Schmidt, Redmond P Smyth
Förderung
- Helmholtz Association of German Research Centres
- Agence Nationale de la Recherche
- Helmholtz Association
- Thematic Institute IMCBio+
- Helmholtz Institute for RNA-based Infection Research (HIRI) Graduate Program
- ERC Starting Grant
- European Molecular Biology Organization
Zitieren
APA
Olguin-Nava, M., Hennig, T., Börtlein, C., Bohn, P., Ambi, U. B., Gabel, A., Günter, L. M., Gribling-Burrer, A. S., Schmidt, N., Caliskan, N., Dölken, L., Munschauer, M., & Smyth, R. P. (2025). High-Fidelity and Cost-Effective Engineering of SARS-CoV-2. Viruses. https://doi.org/10.3390/v17121604
Vancouver
Olguin-Nava M, Hennig T, Börtlein C, Bohn P, Ambi UB, Gabel A, et al. High-Fidelity and Cost-Effective Engineering of SARS-CoV-2. Viruses. 2025. doi:10.3390/v17121604
BibTeX
@article{OlguinNava2025,
author = {Olguin-Nava, Marco and Hennig, Thomas and Börtlein, Charlene and Bohn, Patrick and Ambi, Uddhav B and Gabel, Alexander and Günter, Lina M and Gribling-Burrer, Anne-Sophie and Schmidt, Nora and Caliskan, Neva and Dölken, Lars and Munschauer, Mathias and Smyth, Redmond P},
title = {High-Fidelity and Cost-Effective Engineering of SARS-CoV-2},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17121604}
}
EUVIMED